Dr. Emily Rogalski is a neuroscientist and Associate Professor of Psychiatry and Behavioral Sciences at Northwestern University’s Feinberg School of Medicine. She currently serves as Associate Director of the Mesulam Cognitive Neurology and Alzheimer's Disease Center and as Imaging Core Leader of our NIA-funded Alzheimer’s Disease Center.
Dr. Rogalski research falls under the broad umbrella of aging and dementia and uses a multimodal approach to investigate two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with “normal” or more typical cognitive aging. She receives research support from the National Institutes of Health and other philanthropic sources.
Dr. Rogalski’s investigations assist in defining the clinical and anatomical features of different dementia syndromes over the course of disease as well as identifying genetic and other risk factors. Her lab uses advanced neuroimaging techniques including tau and amyloid PET as well as MRI.
Dr. Rogalski also develop educational programs, support groups, and person-centered intervention programs for families and individuals living with dementia. Her team is currently running a clinical trial investigating the effectiveness of Communication Bridge, a telemedicine person-centered intervention to maximize quality of life for individuals with dementia.